The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 19, 2023
Filed:
Jan. 05, 2021
Applicants:
The Trustees of the University of Pennsylvania, Philadelphia, PA (US);
Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);
Inventors:
David Weiner, Merion, PA (US);
Jian Yan, Wallingford, PA (US);
Assignees:
The Trustees of the University of Pennsylvania, Philadelphia, PA (US);
Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); C07K 14/025 (2006.01); C07K 14/005 (2006.01); A61K 39/145 (2006.01); C12N 7/00 (2006.01); A61N 1/32 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61N 1/327 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/70 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/42 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01); C12N 2760/16022 (2013.01); C12N 2760/16034 (2013.01); C12N 2760/16041 (2013.01); C12N 2760/16071 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16222 (2013.01); C12N 2760/16234 (2013.01); C12N 2800/22 (2013.01);
Abstract
Improved anti-HPV immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus HPV39 E6E7 and HPV45 E6E7. Pharmaceutical composition, recombinant vaccines comprising DNA plasmid and live attenuated vaccines are disclosed as well methods of inducing an immune response in an individual against HPV are disclosed.